Heidemann R, Menke G, Letzel H, Rietbrock N
Dtsch Med Wochenschr. 1985 Oct 11;110(41):1568-72. doi: 10.1055/s-2008-1069048.
Serum levels of glyceryl trinitrate have been determined in eight healthy subjects following transdermal application of four different glyceryl trinitrate plasters using a randomised crossover design. The plasters investigated were Deponit 10, Nitradisc 10, Nitroderm TTS 10 and Nitro-Pflaster-ratiopharm 10. The medians of serum concentrations arranged in decreasing order were 0.17-0.23 ng/ml for Nitroderm TTS 10, 0.13-0.21 ng/ml for Nitradisc 10, 0.08-0.13 ng/ml for Deponit 10, and 0.04-0.09 ng/ml for Nitro-Pflaster-ratiopharm 10. Corresponding areas under the concentration-time curves (AUC 0-24) were 23.15 nmol . h/l (Nitroderm TTS), 20.32 nmol . h/l (Nitradisc), 10.39 nmol . h/l (Deponit), and 5.7 nmol . h/l (Nitro-Pflaster-ratiopharm).
采用随机交叉设计,对8名健康受试者经皮应用4种不同的硝酸甘油贴剂后的血清硝酸甘油水平进行了测定。所研究的贴剂为Deponit 10、Nitradisc 10、Nitroderm TTS 10和Nitro-Pflaster-ratiopharm 10。血清浓度中位数由高到低依次为:Nitroderm TTS 10为0.17 - 0.23 ng/ml,Nitradisc 10为0.13 - 0.21 ng/ml,Deponit 10为0.08 - 0.13 ng/ml,Nitro-Pflaster-ratiopharm 10为0.04 - 0.09 ng/ml。相应的浓度-时间曲线下面积(AUC 0 - 24)分别为:Nitroderm TTS为23.15 nmol·h/l,Nitradisc为20.32 nmol·h/l,Deponit为10.39 nmol·h/l,Nitro-Pflaster-ratiopharm为5.7 nmol·h/l。